Atrovent HFA (ipratropium) is an FDA-approved prescription medication used for the treatment of chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis. It acts by relaxing the muscles of the respiratory tract resulting in increased airflow into the lungs.
It comes in a metered-dose inhaler and contains ipratropium bromide as its active ingredient.
Generic name: ipratropium inhalation
Brand names: Atrovent HFA, Atrovent
Drug class: Anticholinergic bronchodilators
Uses of Atrovent HFA
It is used for the prevention and treatment of bronchospasm in people with chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis.
How To Use Atrovent Inhaler
Follow your doctor’s instructions for using Atrovent HFA. Read all drug guides or instruction sheets and follow all guidelines on your prescription label. In a 24-hour period, do not utilize more than 12 Atrovent HFA inhalations. If you’re using a nebulizer to take this drug, space your doses 6 to 8 hours apart.
Any instructions for use that came with your medicine should be read and followed carefully. If you don’t understand anything, go to your doctor or pharmacist.
Prime the inhaler with two test sprays into the air, away from your face, before using an Atrovent HFA aerosol for the first time. If the inhaler hasn’t been used in more than three days, prime it again. This drug does not need to be shaken before each use.
Atrovent HFA is not a bronchospasm-relieving medication. In the event of an attack, only use fast-acting inhalation medicine. If your breathing issues worsen quickly or you believe your meds aren’t functioning as effectively as they should, see a doctor.
Keep away from moisture, heat, and light. Store at room temperature. When not in use, keep your inhaler covered. Avoid using an open flame or intense heat. If the canister becomes too heated, it may explode. An empty inhaler canister should not be punctured or burned.
Even if it feels like there is still medicine inside, throw away the inhaler canister when the dose indication reaches 0.
Two inhalations of Atrovent HFA four times a day is the typical starting dose. Additional inhalations may be taken by patients as needed, but the total number of inhalations in 24 hours should not exceed 12.
The following side effects can be associated with taking Atrovent HFA. They include mild and severe side effects.
Consult your doctor or pharmacist for further information on any potential adverse effects. They can provide you with advice on how to deal with any unpleasant side effects.
Common mild side effects include:
- bitter taste
- dry mouth
- flu-like symptoms
- shortness of breath
- worsening of COPD
- urinary tract infection
- back pain
Severe side effects include:
- Paradoxical bronchospasm
- New or worsening closed-angle glaucoma
- New or worsening urinary retention
- Serious allergic reactions
Severe side effects are uncommon, but they can happen. If you experience any major side effects, contact your doctor at once. If your symptoms are life-threatening or you believe you’re having a medical emergency, dial 911 or your local emergency number.
If you have glaucoma, do not use Atrovent HFA in your eyes. If you already have bronchospasm, Atrovent HFA won’t help you stop it. Only an attack can be prevented by using it. To treat a bronchospasm attack, use only a fast-acting inhalation medication.
As soon as you see an increase in the severity of your breathing difficulties, make an appointment with a doctor.
Atrovent Inhaler Price
The average retail price for a 12.9g of 17mcg Atrovent inhaler is about $464. The cost may be much lower depending on your insurance plan.
There are also Patient assistance programs (PAPs) available to low-income or uninsured and under-insured people who meet specific guidelines. These programs offer medications at discounted prices.
PAPs for Atripla include:
Atrovent HFA Alternatives
- Incruse Ellipta
- Combivent Respimat
- Anoro Ellipta
Atrovent HFA vs. Albuterol (Ventolin)
Atrovent is a bronchodilator used for the prevention and treatment of bronchospasm in people with chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis while albuterol is a bronchodilator used in asthmatics and people with COPD to relieve shortness of breath.